Skip to content

Drug interactions

Dacomitinib + Tamoxifen

Severity: Major

Dacomitinib and Tamoxifen: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dacomitinib strongly inhibits CYP2D6, which converts tamoxifen to its active metabolite endoxifen. This may reduce tamoxifen efficacy rather than increase it.

What this interaction means in plain words

Dacomitinib and Tamoxifen can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Dacomitinib belongs to Oncology; Tamoxifen belongs to Endocrine.

Evidence level: Moderate

Why it happens

Dacomitinib inhibits CYP2D6, reducing endoxifen formation.

What to do

Avoid the combination where possible, or consider an aromatase inhibitor alternative if appropriate for the patient.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dacomitinib and Tamoxifen, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dacomitinib with Tamoxifen?

MediHelp rates the interaction as major. Dacomitinib and Tamoxifen can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Dacomitinib strongly inhibits CYP2D6, which converts tamoxifen to its active metabolite endoxifen. This may reduce tamoxifen efficacy rather than increase it.

How serious is the interaction between Dacomitinib and Tamoxifen?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible, or consider an aromatase inhibitor alternative if appropriate for the patient.

What other medicines interact with Tamoxifen?

MediHelp also lists interactions of Tamoxifen with, for example, Amiodarone, Anastrozole, Bupropion. The full list is on the Tamoxifen page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in